Keywords: bioalliance, subsid, launch, loramyc, operational, pharma, sa

BioAlliance subsid for launch of Loramyc operational

Article | 08 May 2006

BioAlliance Pharma SA, an emerging French specialty pharmaceutical company focused on the development of innovative therapeutics targeting drug resistance in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Miconazole

Monistat-Derm

Nystatin

Go to drug listing